Gilead Sciences (GILD) Change in Acquisitions & Divestments (2009 - 2026)

Gilead Sciences (GILD) has reported Change in Acquisitions & Divestments for 18 consecutive years, with $36.0 million the latest figure, recorded in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $36.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $890.0 million (up 145.92% YoY), and the FY2025 annual result was $854.0 million, up 161.16% from the prior year.
• Change in Acquisitions & Divestments was $36.0 million for Q1 2026 at Gilead Sciences, down from $340.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $2.3 billion in Q1 2024 and troughed at -$1.9 billion in Q2 2024.
• Average Change in Acquisitions & Divestments over 5 years is $133.7 million, with a median of $161.5 million recorded in 2022.
• The widest YoY moves for Change in Acquisitions & Divestments: up 599.07% in 2024, down 27585.71% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at -$820.0 million in 2022, then jumped by 42.07% to -$475.0 million in 2023, then tumbled by 308.0% to -$1.9 billion in 2024, then jumped by 117.54% to $340.0 million in 2025, then slumped by 89.41% to $36.0 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $36.0 million in Q1 2026, $340.0 million in Q4 2025, and $499.0 million in Q3 2025.